Michael Wasserman

Dr. Michael Wasserman is a high-net-worth investor based in Toronto, Canada. Dr. Wasserman serves as Senior Advisor at H.I.G. BioHealth Partners. Dr. Wasserman served as Managing Partner at Maverix Private Equity. He serves as an Advisor at Nushama. He serves as a Board Member at On Target Laboratories and Zerigo Health. He served as a Board Member at CardioFocus. Dr. Wasserman also serves as an Advisor at Florida Institute for the Commercialization of Public Research. Prior to joining H.I.G., Dr. Wasserman was a Principal at Innovations Foundation, focused on the creation, financing, and development of high-technology companies in the life sciences, information technology, and engineering sectors. He serves as a Board Member at HyperBranch Medical Technology. At Innovations Foundation, he was instrumental in building multiple high-growth companies derived from academic or federally sponsored research programs. He also serves as a Board Member at Orbus Therapeutics. He has also held prominent operating roles in several entrepreneurial and venture-backed life sciences efforts. He was a founder and Vice President, Business Development at CELLutions Biosystems (acquired by Cedarlane Laboratories), where he broadly managed business operations and was directly responsible for the successful negotiation of partnership, co-development, and licensing agreements with industry-leading pharmaceutical and biotechnology organizations. Earlier in his career, he worked directly for or as a consultant to several early-stage life sciences businesses and in the corporate finance, pharmaceutical, and clinical research industries. He manages his own investments.